Multiple Assemblies exist for SMTL entry 6emh
Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor; X-RAY DIFFRACTION 1.76 Å

	SMTL ID 6emh.1 Ligands BETA-MERCAPTOETHANOL; CHLORIDE ION; 4-(4-methyl-1~{H}-imidazol-5-yl)-~{N}-(4-morpholin-4-ylphenyl)pyridin-2-amine; 1,2-ETHANEDIOL; N-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE Polypeptides Mitogen-activated protein kinase 10 Oligo-state monomer
	SMTL ID 6emh.2 Ligands BETA-MERCAPTOETHANOL; 4-(4-methyl-1~{H}-imidazol-5-yl)-~{N}-(4-morpholin-4-ylphenyl)pyridin-2-amine; 1,2-ETHANEDIOL; N-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE Polypeptides Mitogen-activated protein kinase 10 Oligo-state monomer
	SMTL ID 6emh.3 Ligands CHLORIDE ION; DI(HYDROXYETHYL)ETHER; 4-(4-methyl-1~{H}-imidazol-5-yl)-~{N}-(4-morpholin-4-ylphenyl)pyridin-2-amine; 1,2-ETHANEDIOL; GLYCEROL Polypeptides Mitogen-activated protein kinase 10 Oligo-state monomer
	SMTL ID 6emh.4 Ligands CHLORIDE ION; DI(HYDROXYETHYL)ETHER; 4-(4-methyl-1~{H}-imidazol-5-yl)-~{N}-(4-morpholin-4-ylphenyl)pyridin-2-amine; 1,2-ETHANEDIOL; GLYCEROL Polypeptides Mitogen-activated protein kinase 10 Oligo-state monomer